Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 727

The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.

Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer: High incidence of central nervous system metastases

Open access
Lin, Nancy U., Claus, Elizabeth, Sohl, Jessica, Razzak, Abdul R., Arnaout, Amal, Winer, Eric P.·2008·Cancer

Abstract

BACKGROUND.: The purpose of the current study was to characterize the outcomes of patients with metastatic triple‐negative breast cancers, including the risk and clinical consequences of central nervous system (CNS) recurrence. METHODS.: Using pharmacy and pathology records, a study group of 116 patients who were treated for metastatic triple‐negative breast cancer at Dana‐Farber Cancer Institute between January 2000 and June 2006 was identified. RESULTS.: The median survival from time of metastatic diagnosis was 13.3 months. Sixteen patients (14%) were diagnosed with CNS involvement at the time of initial metastatic diagnosis; overall, 46% of patients were diagnosed with CNS metastases before death. The median survival after a diagnosis of CNS metastasis was 4.9 months. The age‐adjusted and race‐adjusted rate of death for patients whose first presentation included a CNS metastasis was 3.4 times (95% confidence interval, 1.9‐6.1 times) that of patients without a CNS lesion at the time of first metastatic presentation. Of the 53 patients who developed brain metastases, only 3 patients were judged to have stable or responsive systemic disease in the face of progressive CNS disease at the last follow‐up before death. CONCLUSIONS.: Triple‐negative breast cancer is associated with poor survival after recurrence. CNS recurrence is common, but death as a direct consequence of CNS progression in the setting of controlled systemic disease is uncommon. Thus, it does not appear that the high rate of CNS involvement is because of a sanctuary effect, but rather is due to the lack of effective therapies in general for this aggressive subtype of breast cancer. New treatment strategies are needed. Cancer 2008. © 2008 American Cancer Society.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/cncr.23930

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 31 references

Cited by

See all 727

Metadata

Authors
Lin, N. U., Claus, E., Sohl, J., Razzak, A. R., Arnaout, A., & Winer, E. P.
Venue
Cancer
Publisher
Wiley
Published
2008-11-03
Volume
113
Issue
10
Pages
2638-2645
ISSN
  • 0008-543X (ISSN-L)
  • 1097-0142
OpenAlex
W2035570331
Cited by
727
References
31
FWCI
7.88
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer: High incidence of central nervous system metastases. https://app.cochat.ai/papers/10.1002/cncr.23930
The paper
Lin, N. U., Claus, E., Sohl, J., Razzak, A. R., Arnaout, A., & Winer, E. P. (2008). Sites of distant recurrence and clinical outcomes in patients with metastatic triple‐negative breast cancer: High incidence of central nervous system metastases. Cancer. https://doi.org/10.1002/cncr.23930

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.